EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation

Yasir S Elhassan iD, Silke Appenzeller, Laura-Sophie Landwehr iD, Juliane Lippert, Dillon Popat iD, Lorna C Gilligan, Lida Abdi, Edwina Goh, Salvador Diaz-Cano, Stefan Kircher, Susanne Gramlich, Robert P Sutcliffe und 5 weitere

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae106 ↗

Kurz gefasst

Fallbericht in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Yasir S Elhassan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom. Hauptthemen laut MEDLINE: Histone Demethylases, Cushing Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a rare cause of Cushing's syndrome. Individuals with PBMAH and glucose-dependent insulinotropic polypeptide (GIP)-dependent Cushing's syndrome due to ectopic expression of the GIP receptor (GIPR) typically harbor inactivating KDM1A sequence variants. Primary unilateral macronodular adrenal hyperplasia (PUMAH) with concomitant glucocorticoid and androgen excess has never been encountered or studied.

Methods

We investigated a woman with a large, heterogeneous adrenal mass and severe adrenocorticotropic hormone-independent glucocorticoid and androgen excess, a biochemical presentation typically suggestive of adrenocortical carcinoma. The patient presented during pregnancy (22nd week of gestation) and reported an 18-month history of oligomenorrhea, hirsutism, and weight gain. We undertook an exploratory study with detailed histopathological and genetic analysis of the resected adrenal mass and leukocyte DNA collected from the patient and her parents.

Results

Histopathology revealed benign macronodular adrenal hyperplasia. Imaging showed a persistently normal contralateral adrenal gland. Whole-exome sequencing of 4 representative nodules detected KDM1A germline variants, benign NM_001009999.3:c.136G > A:p.G46S, and likely pathogenic NM_001009999.3:exon6:c.865_866del:p.R289Dfs*7. Copy number variation analysis demonstrated an additional somatic loss of the KDM1A wild-type allele on chromosome 1p36.12 in all nodules. RNA sequencing of a representative nodule showed low/absent KDM1A expression and increased GIPR expression compared with 52 unilateral sporadic adenomas and 4 normal adrenal glands. Luteinizing hormone/chorionic gonadotropin receptor expression was normal. Sanger sequencing confirmed heterozygous KDM1A variants in both parents (father: p.R289Dfs*7 and mother: p.G46S) who showed no clinical features suggestive of glucocorticoid or androgen excess.

Conclusions

We investigated the first PUMAH associated with severe Cushing's syndrome and concomitant androgen excess, suggesting pathogenic mechanisms involving KDM1A.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone DemethylasesCushing SyndromeHumansFemaleAdultGlucocorticoidsPregnancyAndrogensAdrenal GlandsAdrenal Hyperplasia, Congenital

Stichwörter der Autor:innen

KDM1AMC2RCushing's syndromeGIP receptorPBMAHPUMAHadrenocortical tumorandrogen excess

Substanzen

KDM1A protein, humanHistone DemethylasesGlucocorticoidsAndrogens

Autor:innen und Institutionen

  • Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
  • Centre for Endocrinology, Diabetes and Metabolism, University Hospitals Birmingham NHS Foundation Trust, Birmingham Health Partners, Birmingham, United Kingdom.
  • Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.
  • Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany.
  • Faculty of Medicine and Dentistry, Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • MRC Laboratory of Medical Sciences, London, United Kingdom.

ORCID-Profile: Yasir S Elhassan, Laura-Sophie Landwehr, Dillon Popat, Martin Fassnacht, Wiebke Arlt, Cristina L Ronchi

Förderung

  • Medical Research Council
  • Wellcome Trust
  • Deutsche Forschungsgemeinschaft
  • Collaborative Awards in Science and Engineering
  • HRA Pharma Rare Disease
  • British Society of Paediatric Endocrinology and Diabetes, Barts Charity
  • Academy of Medical Sciences Fellowship Grant
  • AMEND ACC Research Fund 2022

Zitieren

APA

Elhassan, Y. S., Appenzeller, S., Landwehr, L. S., Lippert, J., Popat, D., Gilligan, L. C., Abdi, L., Goh, E., Diaz-Cano, S., Kircher, S., Gramlich, S., Sutcliffe, R. P., Thangaratinam, S., Chan, L. F., Fassnacht, M., Arlt, W., & Ronchi, C. L. (2024). Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae106

Vancouver

Elhassan YS, Appenzeller S, Landwehr LS, Lippert J, Popat D, Gilligan LC, et al. Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae106

BibTeX
@article{Elhassan2024,
  author = {Elhassan, Yasir S and Appenzeller, Silke and Landwehr, Laura-Sophie and Lippert, Juliane and Popat, Dillon and Gilligan, Lorna C and Abdi, Lida and Goh, Edwina and Diaz-Cano, Salvador and Kircher, Stefan and Gramlich, Susanne and Sutcliffe, Robert P and Thangaratinam, Shakila and Chan, Li F and Fassnacht, Martin and Arlt, Wiebke and Ronchi, Cristina L},
  title = {Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae106}
}
Kostenlos starten →